General Information


DRACP ID  DRACP04072

Peptide Name  

Sequence  DGRCLLIIKLAKLAKKLAKLAK

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C111H207N31O25S

Absent amino acids  EFHMNPQSTVWY

Common amino acids  KL

Mass  278292

Pl  11.09

Basic residues  7

Acidic residues  1

Hydrophobic residues  12

Net charge  6

Boman Index  -812

Hydrophobicity  44.09

Aliphatic Index  160

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23326440

Title  Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16628

DRACP is developed by Dr.Zheng's team.